Exogenous L-arginine ameliorates angiotensin II-induced hypertension and renal damage in rats

Hypertension

Volumn 52, Issue 6, 2008, Pages 1084-1090

  Rajapakse, Niwanthi W ^a,b   De Miguel, Carmen ^a   Das, Satarupa ^a   Mattson, David L ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Angiotensin II; Hypertension; Kidney; L arginine; NO

Indexed keywords

ALBUMIN; ANGIOTENSIN II; ARGININE; NITRATE; NITRIC OXIDE; NITRITE;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONCENTRATION (PARAMETERS); DRUG BIOAVAILABILITY; DRUG MECHANISM; HYPERTENSION; KIDNEY INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; URINARY EXCRETION;

ALBUMINURIA; ANGIOTENSIN II; ANIMALS; ARGININE; BLOOD PRESSURE; CONSCIOUSNESS; CREATININE; DRUG INTERACTIONS; GLOMERULAR FILTRATION RATE; HYPERTENSION, RENAL; KIDNEY GLOMERULUS; MALE; NITRATES; NITRIC OXIDE; NITRITES; RATS; RATS, SPRAGUE-DAWLEY; VASOCONSTRICTOR AGENTS;

EID: 57449084343     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.114298     Document Type: Article

References (46)

1. Reckelhoff JF, Romero JC. Role of oxidative stress in angiotensin-induced hypertension. Am J Physiol. 2003;284:R893-R912.
2. Navar LG, Ichihara A, Chin SY, Imig JD. Nitric oxide-angiotensin II interactions in angiotensin II-dependent hypertension. Acta Physiol Scand. 2000;168:139-147.
3. Romero JC, Reckelhoff JF. Role of angiotensin and oxidative stress in essential hypertension. Hypertension. 1999;34:943-949.
4. Johnson RJ, Rodriguez-Iturbe B, Kang D-H, Feig DI, Herrera-Acosta J. A unifying pathway for essential hypertension. Am J Hypertens. 2005;18:431-440.
5. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007;59:251-287.
6. Patzak A, Persson EG. Angiotensin H-nitric oxide interaction in the kidney. Curr Opin Nephrol Hypertens. 2007;16:46-51.
7. Sachse A, Wolf G. Angiotensin II induced reactive oxygen species and the kidney. J Am Soc Nephrol. 2007;18:2439-2446.
8. Ritz E, Haxsen V. Angiotensin II and oxidative stress: an unholy alliance [comment]. J Am Soc Nephrol. 2003;14:2985-2987.
9. Portaluppi F, Boari B, Manfredini R. Oxidative stress in essential hypertension. Curr Pharml Des. 2004;10:1695-1698.
10. Romero JC, Reckelhoff JF. Oxidative stress may explain how hypertension is maintained by normal levels of angiotensin II. Braz J Med Biol Res. 2000;33:653-660.
11. Majid DSA, Kopkan L. Nitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension. Clin Exp Pharmacol Physiol. 2007;34:946-952.
12. Tousoulis D, Antoniades C, Tentolouris C, Goumas G, Stefanadis C, Toutouzas P. L-arginine in cardiovascular disease: dream or reality? Vasc Med. 2002;7:203-211.
13. Baydoun AR, Emery PW, Pearson JD, Mann GE. Substrate-dependent regulation of intracellular amino acid concentrations in cultured bovine aortic endothelial cells, Biochem Biophys Res Commun. 1990;173:940-948.
14. Pollock JFU, Mitchell JA, Warner TD, Schmidt HHHW, Nakane M, Murad F. Purification and characterization of particulate endothelium derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci U S A. 1990;87:8612-8616.
15. Kakoki M, Kim H-S, Arendshorst WJ, Mattson DL. L-Arginine uptake affects nitric oxide production and blood flow in the renal medulla. Am J Physiol. 2004;287:R1478-R1485.
16. Kakoki M, Kim H-S, Edgell C-JS, Maeda N, Smithies O, Mattson DL. Amino acids as modulators of endothelium-derived nitric oxide. Am J Physiol. 2006;291:F297-F304.
17. Deng X, Welch WJ, Wilcox CS. Renal vasodilation with L-arginine. Effects of dietary salt. Hypertension. 1995;26:256-262.
18. Radermacher J, Klanke B, Kastner S, Haake G, Schurek HJ, Stolte HF, Frolich JC. Effect of arginine depletion on glomerular and tubular kidney function: studies in isolated perfused rat kidneys. Am J Physiol. 1991;261:F779-F786.
19. Gokce N. L-arginine and hypertension. J Nutr. 2004;134:2807S- 2811S; discussion 2818S-2819S.
20. Hu L, Manning RD Jr. Role of nitric oxide in regulation of long-term pressure-natriuresis relationship in Dahl rats. Am J Physiol. 1995;268:H2375-H2383.
21. Chen PY, Sanders PW. Role of nitric oxide synthesis in salt sensitive hypertension in Dahl/Rapp rats. Hypertension. 1993;22:812-818.
22. Patel AR, Granger JP, Krichner KA. L-Arginine improves transmission of perfusion pressure to the renal interstitium in Dahl salt-sensitive rats. Am J Physiol. 1994;266:R1730-R1735.
23. Miyata N, Zou AP, Mattson DL, Cowley AW Jr. Renal medullary interstitial infusion of L-arginine prevents hypertension in Dahl salt-sensitive rats. Am J Physiol. 1998;275:R1667-R1673.
24. Siani A, Pagano E, Iacone R, Iacoviello L, Scopacasa F, Strazzullo P. Blood pressure and metabolic changes during dietary L-arginine supplementation in humans. Am J Hypertens. 2000;13:547-551.
25. Chen PY, Sanders PW. L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest. 1991;88:1559-1567.
26. Pagnotta P, Germano G, Gratter G, Leonardo F, Rosano G, Chierchia S. Oral L-arginine supplementation improves essential arterial hypertension. Circulation. 1997;96:538-1.
27. Higashi Y, Oshima T, Ozono R, Wantanabe M, Matsuura H, Kajiyama G. Effects of L-arginine infusion on renal hemodynamics in patients with mild essential hypertension. Hypertension. 1995;25:898-902.
28. Mattson DL, James L, Berdan EA, Meister CJ. Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat. Hypertension. 2008;48:149-156.
29. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 1984;26:137-143.
30. Mattson DL, Kunert MP. Kaldunski ML, Greene AS, Roman RJ, Jacob HJ. Cowley AW Jr. Influence of diet and genetics on hypertension and renal disease in Dahl salt-sensitive rats. Phys Genomics. 2004;16:194-203.
31. Mattson DL, Meister CJ, Marcelle ML. Dietary protein source determines the degree of hypertension and renal disease in the Dahl salt-sensitive rat. Hypertension. 2005;45:736-741.
32. Bruins MJ, Soeters PB, Lamers WH, Meijer AJ, Deutz NEP. L-Arginine supplementation in hyperdynamic endotoxemic pigs: effect on nitric oxide synthesis by the different organs [see comment]. Crit Care Med. 2002;30:508-517.
33. Fike CD, Kaplowitz MR, Rehorst-Paea LA, Nelin LD. L-Arginine increases nitric oxide production in isolated lungs of chronically hypoxic newborn pigs. J Appl Physiol. 2000;88:1797-1803.
34. Kakoki M, Wang W, Mattson DL. Cationic amino acid transport in the renal medulla and blood pressure regulation. Hypertension. 2002;39:287-292.
35. Closs EI, Scheid JS, Sharafi M, Forstermann U. Substrate supply for nitric oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters. Mol Pharmacol. 2000;57:68-74.
36. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim H-S, Smithies O, Le TH, Coffman TM. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A. 2006;103:17985-17990.
37. Hall JE, Brands MW, Henegar JR. Angiotensin II and long-term arterial pressure regulation: the overriding dominance of the kidney. J Am Soc Nephrol. 1999;10:S258-265.
38. Mount PF, Power DA. Nitric oxide in the kidney: functions and regulation of synthesis. Acta Physiol (Oxf). 2006;187:433-446.
39. Crippa G. Microalbuminuria in essential hypertension. J Hum Hypertens. 2002;16:S74-S77.
40. Kurowska EM. Nitric oxide therapies in vascular diseases. Curr Pharmac Des. 2002;8:155-166.
41. Bello E, Caramelo C, Lopez MD, Soldevilla MJ, Gonzalez-Pacheco FR, Rovira A, Delgado RG, Alcazar JM, Martell N, Gonzalez J, Ruilope LM, Casado S. Induction of microalbuminuria by 1-arginine infusion in healthy individuals: an insight into the mechanisms of proteinuria. Am J Kid Dis. 1999;33:1018-1025.
42. Rajagopalan S, Laursen JB, Borthayre A, Kurz S, Keiser J, Haleen S, Giaid A, Harrison DG. Role for endothelin-1 in angiotensin II-mediated hypertension. Hypertension. 1997;30:29-34.
43. Laplante M-A, Wu R, Moreau P, de Champlain J. Endothelin mediates superoxide production in angiotensin II-induced hypertension in rats. Free Radic Biol Med. 2005;38:589-596.
44. Ortiz MC, Manriquez MC, Romero JC, Juncos LA. Antioxidants block angiotensin II-induced increases in blood pressure and endothelin. Hypertension. 2001;38:655-659.
45. Fujii S, Zhang L, Igarashi J, Kosaka H. L-Arginine reverses p47phox and gp91phox expression induced by high salt in Dahl rats. Hypertension. 2003;42:1014-1020.
46. Chowienczyk P, Ritter J. Arginine: NO more than a simple amino acid? Lancet. 1997;350:901-902.